Kent Hospital is a community teaching hospital located in Warwick, Rhode Island. It was a founding member of the Care New England in 1996, along with Women & Infants Hospital and Butler Hospital.

There are 359 beds in Kent Hospital.

During the past decade, Kent Hospital conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 22 clinical trials were completed, i.e. on average, 91.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 9 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kent Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "NSABP Foundation Inc" with 8 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kent Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Kent Hospital" are "Breast Cancer" (12 trials), "Invasive Breast Carcinoma" (5 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (5 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (5 trials) and "Anatomic Stage II Breast Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Kent Hospital" in a lesser frequency.

Most popular intervention types in "Kent Hospital" are "Drug" (48 trials), "Other" (29 trials), "Biological" (18 trials), "Radiation" (9 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Placebo" (11 trials), "Quality-of-Life Assessment" (9 trials), "Paclitaxel" (8 trials) and "Bevacizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Kent Hospital" are 39 trials for "All" genders and 21 trials for "Female" genders.

Currently, there are NaN active trials in "Kent Hospital". undefined are not yet recruiting, 10 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Kent Hospital, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Kent Hospital, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".